Viveve Medical, Inc.
VIVE
$0.00
$0.0050.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | 2.38% | 2.78% | 17.64% | 17.28% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.38% | 2.78% | 17.64% | 17.28% | -- |
| Cost of Revenue | -0.90% | 9.58% | 18.29% | 12.02% | -- |
| Gross Profit | 23.24% | -33.62% | 10.93% | 109.46% | -- |
| SG&A Expenses | 7.02% | 4.39% | -2.45% | -8.44% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.32% | 17.86% | 21.74% | 16.71% | -- |
| Operating Income | -6.30% | -23.43% | -23.04% | -16.53% | -- |
| Income Before Tax | -12.39% | -30.67% | -4.05% | -1.98% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.39% | -30.67% | -4.05% | -1.98% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.33% | 40.87% | 66.17% | 82.25% | -- |
| Net Income | -12.39% | -30.22% | -3.39% | -0.51% | -- |
| EBIT | -6.30% | -23.43% | -23.04% | -16.53% | -- |
| EBITDA | -8.89% | -27.67% | -26.68% | -18.78% | -- |
| EPS Basic | 43.08% | 59.01% | 78.58% | 86.13% | -- |
| Normalized Basic EPS | 46.09% | 59.60% | 74.60% | 84.70% | -- |
| EPS Diluted | 43.08% | 59.01% | 78.58% | 86.13% | -- |
| Normalized Diluted EPS | 46.09% | 59.60% | 74.60% | 84.70% | -- |
| Average Basic Shares Outstanding | 33.34% | 83.70% | 201.60% | 541.37% | -- |
| Average Diluted Shares Outstanding | 33.34% | 83.70% | 201.60% | 541.37% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |